
Jessilin Quint, OD, MBA, FAAO, and Selina McGee, OD, FAAO, provide an overview of meibomian gland dysfunction (MGD) and its causes.

Jessilin Quint, OD, MBA, FAAO, and Selina McGee, OD, FAAO, provide an overview of meibomian gland dysfunction (MGD) and its causes.

Mandy Sallach, OD, overviews initiatives being taken on by the company to combat pediatric myopia.

As part of the sports and performance vision section of the AOA, Vittorio Mena, OD, MS, shares information on how to bolster athletes' performance through enhanced vision care.

Spencer Johnson, OD, FAAO, overviews his talk that gives the best practices for pre- and post-operative management for laser procedures like YAG capsulotomy, peripheral iridotomy, and selective laser trabeculoplasty.

The organization's past-president and treasurer give some insights on what to expect at the 2024 Congress event this October.

The art of scleral lens fitting is coupled with a patient's patience as they neuro-adapt, according to Clark Chang, OD, MSA, MSc, FAAO.

Ruth Shoge, OD, MPH, FAAO, outlines what it means to identify ACES in pediatric patients.

Derek Bryant, incoming AOSA president, is excited about the future of optometry and is dedicated to empowering students to lead and advocate for the profession.

Drs Clark Chang and Tracy Lynn Schroeder Swartz give an overview of their Optometry's Meeting talk on detecting keratoconus early, providing tips for the proper technology to use and how to properly detect high-risk patients.

Key steps include getting a new refraction, nailing the add power, and managing patient expectations.

Tracy Lynn Schroeder Swartz, OD, MS, FAAO, overview the 3 questions to ask before referring a patient for refractive surgery.

Neda Gioia, OD, CNS, FOWNS, outlines the poster entitled, "Clinical Evaluation of a Multi-Ingredient Oral Supplement on Dry Eye Symptoms and Tear Volume," in an interview with Optometry Times.

Christi Closson, OD, FAAO, details unique products from Johnson & Johnson, including a new contact lenses designed specifically for patients with astigmatism.

Drs Erin Draper and Christopher Kuc reiterate the important role optometrists play in identifying biomarkers for neurodegenerative diseases in patients.

Susan Gromacki, OD, MS, FAAO, FSLS, emphasizes the importance of leveraging modern technology and scientific advancements in contact lenses to provide the best possible comfort and vision correction for patients with astigmatism.

Nick Bruns, OD, FAAO, talks refractive surgery, from premium IOL options for patients with cataracts to EVO ICL for patients seeking elective corrective surgery.

Walter Whitley, OD, MBA, FAAO, weighs in on the importance of staying in the know of innovations in treatment options for the sake of patient care.

Rafieetary emphasizes the importance of follow-up plans and consistent support to prevent patients from dropping out of treatment, which can negatively impact their prognosis.

Gromacki shares the importance of a dedicated approach to treating keratoconus, highlighting the need for passion, diverse tools, and a committed practice environment to ensure patient success.

Raman Bhakrhi, OD, FAAO, said that optometrists' collaboration with primary care physicians and other medical professionals can help minimize the chance for retinal damage caused by medications.

Devin Sasser, OD, gives an overview of a panel and breakout session that the American Optometric Student Association will be hosting at AOA's Optometry's Meeting.

Jacobi Cleaver, OD, FAAO, gives an overview of a panel on allyship given by Black Eyecare Perspective at their event hosted at AOA 2024.

Jade Coats, OD, alongside Jacqueline Theis, OD, FAAO, and Cory Lappin, OD, MS, FAAO, gave a talk on ocular pain and patient care at AOA's 2024 Optometry's Meeting.

Jade Coats, OD, details 2 poster presentations on the benefits found in a novel lipid-containing eye drop during AOA's 2024 Optometry's Meeting.

According to Adam Alexander, OD, Miebo can make headway in establishing a need for precision medication when it comes to dry eye treatment.

Lorraine Provencher, MD, reviews the NOVA trial which measured and validated the sensitivity of a novel VR-based wearable headset for visual field testing in glaucoma.

The rabbit model found that the levels of the active metabolites were very comparable, whether or not eyes had received a prior installation of perfluorohexyloctane.

Representatives from CooperVision and the International Agency for the Prevention of Blindness give a preview of what to expect at the "Universal Access to Glasses: Promoting Multisectoral Action" event at this year's World Health Assembly in Geneva, Switzerland.

Nazlee Zebardast, MD, MSc, overviews her 2 presentations from ARVO 2024 that utilized polygenic risk scores to identify patients' genetic risk of developing low risk for different glaucoma subtypes.

Michael Belin, MD, weighs the ABCD and Amsler-Krumeich classifications and proposes ABCD progression displays as an effective modern alternative.